Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Clinical trial NCT04789486 · RECRUITING

Trial details

NCT number: NCT04789486
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Advanced Pancreatic Adenocarcinoma Unresectable Pancreatic Cancer Ductal Adenocarcinoma of the Pancreas

Start date: 2021-05-27
Primary completion: 2028-04-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.